An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis

Open access

Abstract

Background: Recommendations have been made, following the multicenter Surviving Sepsis Campaign study, to standardize the definition of severe sepsis with reference to several parameters such as haemodynamic stability, acid-base balance, bilirubin, creatinine, International Normalized Ratio (INR), urine output and pulmonary functional value of the ratio between arterial oxigen partial pressure and inspiratory oxigen concentration. Procalcitonin (PCT) is considered to be a gold standard biomarker for the inflammatory response, and recent studies have shown that it may help to discover whether a seriously ill person is developing sepsis. C-reactive protein (CRP) is also used as a marker of inflammation in the body, as its blood levels increase if there is any inflammation in the body. The aim of this study was to evaluate serum procalcitonin and C-reactive protein levels as diagnostic and prognostic biomarkers of severe sepsis.

Material and method: Sixty patients, diagnosed as being “septic”, were admitted to the intensive care unit (ICU). Based on laboratory results and clinical findings a diagnosis of “severe sepsis“ was made, and correlated with PCT and CRP values. The APACHE II, SAPS II and SOFA severity scores were calculated, analyzed and correlated with PCT and CRP.

Results: Fifty two patients (86.67%) presented with criteria for severe sepsis. Multivariate correlation analysis indicated a significant positive association between procalcitonin and all severity scores (APACHEII p<0.0001, SOFA p<0.0001, SAPS II p<0.0001). CRP proved to be significantly correlated only with the SAPS II score (p=0.0145). Mortality rate was high, with 48 patients (80%) dying. There was no significant correlation between the levels of the PCT and CRP biomarkers and severe sepsis (p=0.2059 for PCT, p=0.6059 for CRP).

Conclusions: The procalcitonin levels are highly correlated with the severity scores (APACHE II, SAPS II, SOFA) regularly used in ICUs and therefore can be used for determining the severity of the septic process. Quantitive procalcitonin and C-reactive protein analysis was not shown to be useful in diagnosing severe sepsis. However, PCT and CRP can be used to predict the fatal progression of the septic patient.

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.

2. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946-55.

3. Bone R, Balk R, Cerra F, et al. Definitions for sepsisand organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of ChestPhysicians / Society of Critical Care Medicine”. Chest. 1992;101: 1644-55.

4. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: Sampling, selection, and society. Crit Care. 2004;8:222-6.

5. Hervald H, Egesten A. Sepsis. Pro-Inflammatory and Anti- Inflammatory Responses. Controb Microbiol. Basel, Krager, 2011, vol 17, pp 1-11.

6. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Crit Care Med. 2013;41:580-637.

7. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004; 19:152-7.

8. James D. Faix. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23-36.

9. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. J Crit Care Med. 2015;1:18-23.

10. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg. 1999;384:33-8.

11. Enguix-Armada A, Escobar-Conesa R, La Torre AG, De La Torre- Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2015 17. pii: /j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print]

12. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40:358-65.

13. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ ATS/ SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31:1250-6.

14. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-53.

15. Nargis W, Ibrahim Md, Adamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4:195-9.

16. Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19:637-57.

17. Magill SS, Dumyati G, Ray SM, Fridkin SK. Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States. Emerg Infect Dis. 2015;21:1537-42.

18. Que YA, Guessous I, Dupuis-Lozeron E, et al. Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest. 2015;148:674-82.

19. Enguix-Armada A, Escobar-Conesa R, La Torre AG et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and midregional pro-adrenomedullin. Clin Chem Lab Med. 2015. pii:/j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print].

20. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults. A Multicenter {rospective Study in Intensive Care Units. JAMA. 1995;274:968-74.

21. Hinriksdóttir G, Tryggvadóttir Á, Ólafsdóttir AS, et al. Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents. PLoS One. 2015;10:e0130597. doi: 10.1371/journal.pone.0130597. eCollection 2015.

22. Parrett AL, Valentine RJ, Arngrímsson SA et al. Adiposity, activity, fitness, and C-reactive protein in children. Med Sci Sports Exerc. 2010;42:1981-6.

23. Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit. 2014;4:195-9.

24. Akcay I, Okoh AK, Yalav O, et al. The prognostic value of procalcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Ulus Travma Acil Cerrahi Derg. 2014;20:343-352.

Journal Information

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 240 240 43
PDF Downloads 82 82 16